A feasibility study of combination therapy with trastuzumab (T), cyclophosphamide (CY), and an allogeneic GM-CSF-secreting breast tumor vaccine for the treatment of HER2+ metastatic breast cancer

Journal article

Peer reviewed

L. A. Emens, R. Gupta, S. Petrik, M. Laiko, J. M. Leatherman, J. Levi, J. M. Asquith, M. M. Daphtary, E. Garrett-Mayer, B. J. Kobrin, …

Journal of clinical oncology, Vol.29(15_suppl), pp.2535-2535

2011-05-20

Metrics

5 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.119 Breast Cancer Scanning; 1.119.259 HER2
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A feasibility study of combination therapy with trastuzumab (T), cyclophosphamide (CY), and an allogeneic GM-CSF-secreting breast tumor vaccine for the treatment of HER2+ metastatic breast cancer
Creators: L. A. Emens
R. Gupta
S. Petrik
M. Laiko
J. M. Leatherman
J. Levi
J. M. Asquith
M. M. Daphtary
E. Garrett-Mayer
B. J. Kobrin
N. E. Davidson
T. Dauses
S. Atay-Rosenthal
X. Ye
A. C. Wolff
V. Stearns
E. M. Jaffee
Publication Details: Journal of clinical oncology, Vol.29(15_suppl), pp.2535-2535
Academic Unit: UMMG Department of Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031757924902976